XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Shares at beginning of year (in shares) at Dec. 31, 2018     71,856           45,822
Accumulated derivative instrument gain, beginning of year at Dec. 31, 2018 $ 168,331 $ 0 $ 719 $ 447,337 $ 1,296   $ 237,308 $ (168) $ (518,329)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 130,862           130,862    
Issuance for stock-based compensation and dividend equivalents, net of forfeitures (in shares)     346            
Issuance for stock-based compensation and dividend equivalents, net of forfeitures 0   $ 3 846     (849)    
Stock-based compensation expense $ 11,007     11,007          
Employee stock purchase plan (in shares) (17)               (17)
Employee stock purchase plan $ 558     355         $ 203
Dividends (16,608)           (16,608)    
Defined benefit pension plans, net of tax (2,183)       (2,183)        
Change in fair value of interest rate swap, net of tax (807)       (807)        
Repurchases of common stock (in shares)                 3,472
Repurchases of common stock (123,897)               $ (123,897)
Shares at end of year (in shares) at Dec. 31, 2019     72,202           49,277
Accumulated derivative instrument gain (loss), end of year at Dec. 31, 2019 167,263 $ (214) $ 722 459,545 (1,526) $ 0 350,545 $ (214) $ (642,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 56,039           56,039    
Issuance for stock-based compensation and dividend equivalents, net of forfeitures (in shares)     398            
Issuance for stock-based compensation and dividend equivalents, net of forfeitures 0   $ 4 934     (938)    
Stock-based compensation expense $ 11,595     11,595          
Employee stock purchase plan (in shares) (19)               (19)
Employee stock purchase plan $ 549     304         $ 245
Dividends (16,787)           (16,787)    
Defined benefit pension plans, net of tax (1,706)       (1,706)        
Change in fair value of interest rate swap, net of tax (1,191)       (1,191)        
Repurchases of common stock (in shares)                 1,169
Repurchases of common stock (35,613)               $ (35,613)
Shares at end of year (in shares) at Dec. 31, 2020     72,600           50,427
Accumulated derivative instrument gain (loss), end of year at Dec. 31, 2020 179,935   $ 726 472,378 (4,423)   388,645   $ (677,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 75,177           75,177    
Issuance for stock-based compensation and dividend equivalents, net of forfeitures (in shares)     397            
Issuance for stock-based compensation and dividend equivalents, net of forfeitures 0   $ 4 1,102     (1,106)    
Stock-based compensation expense $ 13,999     13,999          
Employee stock purchase plan (in shares) (15)               (15)
Employee stock purchase plan $ 762     557         $ 205
Dividends (20,120)           (20,120)    
Defined benefit pension plans, net of tax 3,103       3,103        
Change in fair value of interest rate swap, net of tax 1,941       1,941        
Repurchases of common stock (in shares)                 1,080
Repurchases of common stock (66,391)               $ (66,391)
Shares at end of year (in shares) at Dec. 31, 2021     72,997           51,492
Accumulated derivative instrument gain (loss), end of year at Dec. 31, 2021 $ 188,406   $ 730 $ 488,036 $ 621   $ 442,596   $ (743,577)